Institut Català de la Salut
[Rodríguez-Perálvarez M] Department of Hepatology and Liver Transplantation, Hospital Universitario Reina Sofía, IMIBIC, CIBERehd, Córdoba, Spain. [Gómez-Bravo MÁ] Department of Abdominal Surgery and Transplantation, Hospital Universitario Virgen del Rocío, Sevilla, Spain. [Sánchez-Antolín G] Department of Hepatology and Liver Transplantation, Hospital Universitario Rio Hortega, Valladolid, Spain. [De la Rosa G] Organización Nacional de Trasplantes, Madrid, Spain. [Bilbao I] Servei de Trasplantament de Fetge, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Colmenero J] Department of Hepatology and Liver Transplantation, Hospital Clínic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain
Vall d'Hebron Barcelona Hospital Campus
2021-07-19T09:48:01Z
2021-07-19T09:48:01Z
2021-03-01
Trasplantament de fetge; Hepatitis C; Consens
Trasplante de hígado; Hepatitis C; Consenso
Liver Transplantation; Hepatitis C; Consensus
Background. The number of patients awaiting liver transplantation (LT) in Spain has halved from 2015 to 2019 due to the reduction of candidates with hepatitis C and the successful implementation of nonheart beating donation programs across the country. The Spanish Society for Liver Transplantation has committed to take advantage of this situation by developing consensus around potential areas to expand the current indications for LT. The consensus group was composed of 6 coordinators and 23 expert delegates, each one representing an LT institution in Spain. Methods. A modified Delphi approach was used to identify areas to expand indications for LT and to build consensus around paramount aspects, such as inclusion criteria and waitlist prioritization within each area. The scientific evidence and strength of recommendations were assessed by the “Grading of Recommendations Assessment, Development, and Evaluation” system. Results. The consensus process resulted in the identification of 7 potential areas to expand criteria in LT: recipient’s age, hepatocellular carcinoma, alcoholic hepatitis, acute-on-chronic liver failure, hilar and intrahepatic cholangiocarcinoma, and unresectable liver metastases of colorectal cancer. Conclusions. We present the main recommendations issued for each topic, together with their core supporting evidence. These recommendations may allow for expanding criteria for LT homogenously in Spain and may provide a guidance to other countries/institutions facing a similar scenario.
Article
Published version
English
Fetge - Trasplantació - Espanya; Hepatitis C; ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Cell- and Tissue-Based Therapy::Tissue Transplantation::Liver Transplantation; DISEASES::Virus Diseases::Hepatitis, Viral, Human::Hepatitis C; GEOGRAPHICALS::Geographic Locations::Europe::Spain; TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::tratamientos basados en células y tejidos::trasplante de tejidos::trasplante de hígado; ENFERMEDADES::virosis::hepatitis viral humana::hepatitis C; DENOMINACIONES GEOGRÁFICAS::localizaciones geográficas::Europa (continente)::España
Lippincott, Williams & Wilkins
Transplantation;105(3)
http://journals.lww.com/10.1097/TP.0000000000003281
Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
Articles científics - HVH [3439]